Newsroom | 12210 results

BETHESDA, Md.--(BUSINESS WIRE)--CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) – a common condition, particularly in women, where patients experience cardiovascular symptoms despite having no flow-limiting blockages in their major epicardial arteries – using machine learning at the American College of Cardiology’s Annual Scientific Session (ACC.26), taking place March...

BESANÇON, France--(BUSINESS WIRE)--Pixee Medical, a pioneer in Augmented Reality (AR) guidance for orthopedic surgery, today announced it has received CE mark for Knee+ NexSight, its new AR-based solution for total knee arthroplasty, with the first procedures already performed in Europe. Knee+ NexSight is already generating strong momentum in the field, with more than 20 procedures performed across France and Belgium by six surgeons, highlighting rapid adoption and clear clinical interest. The...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, a leading, privately held anesthesia practice management firm, today announced the expansion of its partnership with Washington Regional Medical Center to provide anesthesia services at two additional facilities in Northwest Arkansas: Washington Regional’s North Hills Surgery Center and Physicians’ Specialty Hospital. These strategic additions reflect Premier Anesthesia’s ongoing commitment in Arkansas and further strengthen its collaboratio...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia...

AUSTIN, Texas--(BUSINESS WIRE)--Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has entered the New Jersey market through its partnership with Affiliated Dermatologists & Dermatologic Surgeons (“Affiliated”). Affiliated is a long-established dermatology practice dedicated to providing high-quality care in a comfortable and convenient environment. The team believes that well-informed patients are better eq...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced positive 24-month results from the pivotal U.S. clinical trial of the ELIOS System. Developed for the treatment of elevated intraocular pressure (IOP) in patients with open angle glaucoma, ELIOS is an implant-free procedure that uses next generation excimer laser technology. The ELIOS procedure is currently CE m...

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare vient de recevoir six prix prestigieux au FICCI Advantage Healthcare India 2026, le sommet international sur les voyages médicaux , soulignant son leadership et son excellence dans la prestation de soins de santé à l'échelle mondiale. Ces distinctions, présentées lors du sommet de trois jours qui s’est tenu du 23 au 25 février 2026 dans le cadre des FICCI Medical Value Travel Awards, consolident la réputation de Fortis en tant que partenaire de conf...

ORLANDO, Fla.--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers. As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential...

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare has been honored with six prestigious awards at the FICCI Advantage Healthcare India, International Summit on Medical Value Travel....

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA). The System utilizes proximal hypoglossal nerve stimulation (p-HGNS), a differentiated neurostimulation modality, to treat OSA in patients with an apnea-hypopnea index (AHI) between 15 and 65...